Particle.news

Download on the App Store

AI Voice Biomarkers Discern Vocal Fold Lesions and Early Laryngeal Cancer in Men

The proof-of-principle study used 12,523 recordings to identify key acoustic markers in men’s voices, leaving women’s recordings untested.

Overview

  • The proof-of-principle analysis relied on the public Bridge2AI-Voice dataset, which includes 12,523 recordings from 306 participants across North America.
  • Harmonic-to-noise ratio variability and fundamental frequency differences clearly distinguished healthy vocal folds from benign lesions and early laryngeal cancer in male voices.
  • No statistically informative acoustic features emerged from women’s recordings, underscoring the need for more gender-balanced, diverse data.
  • Diagnostic subgroups were limited—122 participants with healthy vocal folds, 13 with benign lesions and 10 with cancer—restricting the study’s statistical power.
  • Study authors recommend building larger, professionally labeled, multi-institutional datasets and conducting clinical validation before AI-driven voice screening tools enter pilot testing.